Bibliografías temáticas / Interleukin-6 / Artículos de revistas
Siga este enlace para ver otros tipos de publicaciones sobre el tema: Interleukin-6.

Artículos de revistas sobre el tema "Interleukin-6"

Autor: Grafiati
Publicado: 4 de junio de 2021
Última modificación: 1 de julio de 2024

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Interleukin-6".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

&NA;. "Interleukin-3/interleukin-6". Reactions Weekly &NA;, n.º 550 (mayo de 1995): 11. http://dx.doi.org/10.2165/00128415-199505500-00035.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

&NA;. "Interleukin-6". Reactions Weekly &NA;, n.º 570 (septiembre de 1995): 9. http://dx.doi.org/10.2165/00128415-199505700-00023.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Lotz, Martin. "Interleukin-6". Cancer Investigation 11, n.º 6 (enero de 1993): 732–42. http://dx.doi.org/10.3109/07357909309046948.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

&NA;. "Interleukin 6". Inpharma Weekly &NA;, n.º 877 (marzo de 1993): 2. http://dx.doi.org/10.2165/00128413-199308770-00001.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

&NA;. "Interleukin 6". Reactions Weekly &NA;, n.º 505 (junio de 1994): 8. http://dx.doi.org/10.2165/00128415-199405050-00037.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

&NA;. "Interleukin 6". Reactions Weekly &NA;, n.º 531 (diciembre de 1994): 8. http://dx.doi.org/10.2165/00128415-199405310-00027.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Song, Mingchen y John A. Kellum. "Interleukin-6". Critical Care Medicine 33, Suppl (diciembre de 2005): S463—S465. http://dx.doi.org/10.1097/01.ccm.0000186784.62662.a1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

CASTELL, JOSé V., TILO ANDUS, DIETER KUNZ y PETER C. HEINRICH. "Interleukin-6". Annals of the New York Academy of Sciences 557, n.º 1 (28 de junio de 2008): 87–101. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24001.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

LEE, FRANK, CHOY-PIK CHIU, JANUSZ WIDEMAN, PHILLIP HODGKIN, SUSAN HUDAK, LOUISE TROUTT, THERESA NG et al. "Interleukin-6". Annals of the New York Academy of Sciences 557, n.º 1 (28 de junio de 2008): 215–29. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24015.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

CLARK, STEVEN C. "Interleukin-6". Annals of the New York Academy of Sciences 557, n.º 1 (28 de junio de 2008): 438–43. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24036.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

Olencki, Thomas, James Finke y Ronald M. Bukowski. "Interleukin-6". Clinical Immunotherapeutics 2, n.º 4 (octubre de 1994): 278–94. http://dx.doi.org/10.1007/bf03258528.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Sin, Don D. y S. F. Paul Man. "Interleukin-6". Chest 133, n.º 1 (enero de 2008): 4–6. http://dx.doi.org/10.1378/chest.07-2085.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Delk, Nikki A. y Mary C. Farach-Carson. "Interleukin-6". Autophagy 8, n.º 4 (abril de 2012): 650–63. http://dx.doi.org/10.4161/auto.19226.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

Matsuda, Tadashi y Toshio Hirano. "Interleukin 6 (IL-6)". Biotherapy 2, n.º 4 (octubre de 1990): 363–73. http://dx.doi.org/10.1007/bf02170085.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Rivera-Chavez, Fernando A., Dixie L. Peters-Hybki, Robert C. Barber y Grant E. O'Keefe. "Interleukin-6 Promoter Haplotypes and Interleukin-6 Cytokine Responses". Shock 20, n.º 3 (septiembre de 2003): 218–23. http://dx.doi.org/10.1097/00024382-200309000-00004.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Ridker, Paul M. "Targeting Interleukin-1 and Interleukin-6". Journal of the American College of Cardiology 76, n.º 15 (octubre de 2020): 1774–76. http://dx.doi.org/10.1016/j.jacc.2020.08.052.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

NORTHEMANN, WOLFGANG, TODD A. BFUCIAK, MASAHIRA HATTORI y GEORG H. FEY. "Rat Interleukin-6". Annals of the New York Academy of Sciences 557, n.º 1 (28 de junio de 2008): 536–39. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24057.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Schneider, Kirsten, Reinhard Klaas, Bernd Kaspers y Peter Staeheli. "Chicken interleukin-6". European Journal of Biochemistry 268, n.º 15 (1 de agosto de 2001): 4200–4206. http://dx.doi.org/10.1046/j.1432-1327.2001.02334.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

Tamura, T., N. Udagawa, N. Takahashi, C. Miyaura, S. Tanaka, Y. Yamada, Y. Koishihara, Y. Ohsugi, K. Kumaki y T. Taga. "Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6." Proceedings of the National Academy of Sciences 90, n.º 24 (15 de diciembre de 1993): 11924–28. http://dx.doi.org/10.1073/pnas.90.24.11924.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Ogawa, Michio, Kiyoshi Sakamoto, Seiji Mita, Takatoshi Ishiko y Saburo Hisano. "INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR IN SURGICAL TRAUMA". Shock 4, Supplement (diciembre de 1995): 11. http://dx.doi.org/10.1097/00024382-199512001-00045.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

De Filippo, G., D. Rendina, F. Moccia, V. Rocco y A. Campanozzi. "Interleukin-6, soluble interleukin-6 receptor/interleukin-6 complex and insulin resistance in obese children and adolescents". Journal of Endocrinological Investigation 38, n.º 3 (23 de septiembre de 2014): 339–43. http://dx.doi.org/10.1007/s40618-014-0176-4.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Oka, Masaaki, Hiroshi Kusanagi, Toshihiro Saeki, Norio Iizuka, Hiroto Hayashi, Akira Tangoku, Takuo Murakami y Takashi Suzuki. "Interleukin-6 Production and Interleukin-6 Receptor Expression in Human Esophageal Cancer Cell Lines". Japanese Journal of Gastroenterological Surgery 26, n.º 11 (1993): 2707. http://dx.doi.org/10.5833/jjgs.26.2707.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Prens, Errol P., Klazina Benne, Jozef van Damme, Marleen Bakkus, Karin Brakel, Robbert Benner y Theodoor van Joost. "Interleukin-1 and Interleukin-6 in Psoriasis". Journal of Investigative Dermatology 95, n.º 6 (diciembre de 1990): S121—S124. http://dx.doi.org/10.1111/1523-1747.ep12874991.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Bota, Rafaqat y Mushtaq Ahmed. "The pathophysiological profile of interleukin-6 and anti-interleukin-6 antibody". El Mednifico Journal 1, n.º 2 (6 de julio de 2013): 51. http://dx.doi.org/10.18035/emj.v1i2.26.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Ridker, Paul M. y Manas Rane. "Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease". Circulation Research 128, n.º 11 (28 de mayo de 2021): 1728–46. http://dx.doi.org/10.1161/circresaha.121.319077.

Texto completo
Resumen
IL (interleukin)-6 is a pivotal cytokine of innate immunity, which enacts a broad set of physiological functions traditionally associated with host defense, immune cell regulation, proliferation, and differentiation. Following recognition of innate immune pathways leading from the NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome to IL-1 to IL-6 and on to the hepatically derived clinical biomarker CRP (C-reactive protein), an expanding literature has led to understanding of the proatherogenic role for IL-6 in cardiovascular disease and thus the potential for IL-6 inhibition as a novel method for vascular protection. In this review, we provide an overview of the mechanisms by which IL-6 signaling occurs and how that impacts upon pharmacological inhibition; describe murine models of IL-6 and atherogenesis; summarize human epidemiological data outlining the utility of IL-6 as a biomarker of vascular risk; outline genetic data suggesting a causal role for IL-6 in systemic atherothrombosis and aneurysm formation; and then detail the potential role of IL-6 inhibition in stable coronary disease, acute coronary syndromes, heart failure, and the atherothrombotic complications associated with chronic kidney disease and end-stage renal failure. Finally, we review anti-inflammatory and antithrombotic findings for ziltivekimab, a novel IL-6 ligand inhibitor being developed specifically for use in atherosclerotic disease and poised to be tested formally in a large-scale cardiovascular outcomes trial focused on individuals with chronic kidney disease and elevated levels of CRP, a population at high residual atherothrombotic risk, high residual inflammatory risk, and considerable unmet clinical need.
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

Jucker, M., H. Abts, W. Li, R. Schindler, H. Merz, A. Gunther, C. von Kalle, M. Schaadt, T. Diamantstein y AC Feller. "Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease". Blood 77, n.º 11 (1 de junio de 1991): 2413–18. http://dx.doi.org/10.1182/blood.v77.11.2413.2413.

Texto completo
Resumen
Abstract Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute- phase proteins in liver cells. It has been suggested that IL-6 is involved in the pathogenesis of several diseases by autocrine or paracrine pathways. To examine whether IL-6 is possibly involved in the pathophysiology of Hodgkin's disease (HD), we analyzed the expression of IL-6 and IL-6 receptor mRNA and protein in cell lines and primary specimens from patients with HD. IL-6-specific transcripts were detected in three of six HD-derived cell lines by Northern blot analysis. In the culture supernatants of four HD-derived cell lines, IL- 6 was detected by radioimmunoassay. Biologic activity of IL-6 was confirmed by proliferation of an IL-6-dependent cell line. In situ hybridization experiments showed IL-6-specific transcripts in Hodgkin (H) and Reed-Sternberg (RS) cells in primary tissues of two patients. In addition, mRNAs specific for the IL-6 receptor were detected in five HD-derived cell lines. Immunostaining experiments showed expression of IL-6 receptor molecules on H and RS cells in 8 of 16 cases with HD. Thus, our data suggest that IL-6 might be involved in the pathophysiology of HD.
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Jucker, M., H. Abts, W. Li, R. Schindler, H. Merz, A. Gunther, C. von Kalle, M. Schaadt, T. Diamantstein y AC Feller. "Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease". Blood 77, n.º 11 (1 de junio de 1991): 2413–18. http://dx.doi.org/10.1182/blood.v77.11.2413.bloodjournal77112413.

Texto completo
Resumen
Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute- phase proteins in liver cells. It has been suggested that IL-6 is involved in the pathogenesis of several diseases by autocrine or paracrine pathways. To examine whether IL-6 is possibly involved in the pathophysiology of Hodgkin's disease (HD), we analyzed the expression of IL-6 and IL-6 receptor mRNA and protein in cell lines and primary specimens from patients with HD. IL-6-specific transcripts were detected in three of six HD-derived cell lines by Northern blot analysis. In the culture supernatants of four HD-derived cell lines, IL- 6 was detected by radioimmunoassay. Biologic activity of IL-6 was confirmed by proliferation of an IL-6-dependent cell line. In situ hybridization experiments showed IL-6-specific transcripts in Hodgkin (H) and Reed-Sternberg (RS) cells in primary tissues of two patients. In addition, mRNAs specific for the IL-6 receptor were detected in five HD-derived cell lines. Immunostaining experiments showed expression of IL-6 receptor molecules on H and RS cells in 8 of 16 cases with HD. Thus, our data suggest that IL-6 might be involved in the pathophysiology of HD.
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Plenz, Gabriele, Heike Eschert, Michael Erren, Thomas Wichter, Michael Böhm, Markus Flesch, Hans H. Scheld y Mario C. Deng. "The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts". Journal of the American College of Cardiology 39, n.º 9 (mayo de 2002): 1508–12. http://dx.doi.org/10.1016/s0735-1097(02)01791-6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

Nancey, Stéphane, Nadim Hamzaoui, Driffa Moussata, Ivan Graber, Jacques Bienvenu y Bernard Flourie. "Serum Interleukin-6, Soluble Interleukin-6 Receptor and Crohn’s Disease Activity". Digestive Diseases and Sciences 53, n.º 1 (5 de junio de 2007): 242–47. http://dx.doi.org/10.1007/s10620-007-9849-6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Angelis, Pela, Simon Scharf, Alastair Mander, Frank Vajda y Nicholas Christophidis. "Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease". Neuroscience Letters 244, n.º 2 (marzo de 1998): 106–8. http://dx.doi.org/10.1016/s0304-3940(98)00136-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Rezai, Ali R., Ahmad Rezai, Otoniel Mart�nez-Maza, Meta Vander-Meyden y Martin H. Weiss. "Interleukin-6 and interleukin-6 receptor gene expression in pituitary tumors". Journal of Neuro-Oncology 19, n.º 2 (junio de 1994): 131–35. http://dx.doi.org/10.1007/bf01306454.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

MONTERO-JULIAN, F. A., E. GAUTHEROT, J. WIJDENES, B. KLEIN y H. BRAILLY. "Pharmacokinetics of Interleukin-6 During Therapy with Anti-Interleukin-6 Monoclonal Antibodies: Enhanced Clearance of Interleukin-6 by a Combination of Three Anti-Interleukin-6 Antibodies". Journal of Interferon Research 14, n.º 5 (octubre de 1994): 301–2. http://dx.doi.org/10.1089/jir.1994.14.301.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

KENIS, G., C. TEUNISSEN, R. DEJONGH, E. BOSMANS, H. STEINBUSCH y M. MAES. "STABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM". Cytokine 19, n.º 5 (septiembre de 2002): 228–35. http://dx.doi.org/10.1016/s1043-4666(02)91961-7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Kenis, Gunter, Charlotte Teunissen, Raf De Jongh, Eugène Bosmans, Harry Steinbusch y Michael Maes. "STABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM". Cytokine 19, n.º 5 (septiembre de 2002): 228–35. http://dx.doi.org/10.1006/cyto.2002.1961.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

HIRANO, TOSHIO. "Interleukin 6 (IL-6) and disease." Japanese Journal of Clinical Immunology 13, n.º 5 (1990): 444–45. http://dx.doi.org/10.2177/jsci.13.444.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Van Wagoner, N. J. y E. N. Benveniste. "Interleukin-6 regulation in human astrocytes: Synergy between TNF-alpha, interleukin-6, and the soluble-interleukin-6 receptor-alpha". Journal of Neuroimmunology 90, n.º 1 (septiembre de 1998): 53. http://dx.doi.org/10.1016/s0165-5728(98)91497-7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

Hoejberg, Lise, Lars Bastholt y Henrik Schmidt. "Interleukin-6 and melanoma". Melanoma Research 22, n.º 5 (octubre de 2012): 327–33. http://dx.doi.org/10.1097/cmr.0b013e3283543d72.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

Rose-John, Stefan. "Interleukin-6 Family Cytokines". Cold Spring Harbor Perspectives in Biology 10, n.º 2 (15 de junio de 2017): a028415. http://dx.doi.org/10.1101/cshperspect.a028415.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Tanaka, Toshio, Masashi Narazaki y Tadamitsu Kishimoto. "Interleukin (IL-6) Immunotherapy". Cold Spring Harbor Perspectives in Biology 10, n.º 8 (4 de agosto de 2017): a028456. http://dx.doi.org/10.1101/cshperspect.a028456.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

Suzuki, Kenshi, Akiko Miyashita, Yasuyuki Inoue, Seiko Iki, Hidetoshi Enomoto, Yuji Takahashi y Tamiko Takemura. "Interleukin-6-Producing Pheochromocytoma". Acta Haematologica 85, n.º 4 (1991): 217–19. http://dx.doi.org/10.1159/000204897.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Kerr, Ron, David Stirling y Christopher A. Ludlam. "Interleukin 6 and Haemostasis". British Journal of Haematology 115, n.º 1 (octubre de 2001): 3–12. http://dx.doi.org/10.1046/j.1365-2141.2001.03061.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Sehgal, Pravinkumar B. "Interleukin-6: Molecular Pathophysiology". Journal of Investigative Dermatology 94, n.º 6 (junio de 1990): s2—s6. http://dx.doi.org/10.1111/1523-1747.ep12874963.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Van Snick, Jacques. "Interleukin-6: An Overview". Annual Review of Immunology 8, n.º 1 (abril de 1990): 253–78. http://dx.doi.org/10.1146/annurev.iy.08.040190.001345.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Pedersen, Bente Klarlund, Adam Steensberg y Peter Schjerling. "Exercise and interleukin-6". Current Opinion in Hematology 8, n.º 3 (mayo de 2001): 137–41. http://dx.doi.org/10.1097/00062752-200105000-00002.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Patarca, Roberto y Mary Ann Fletcher. "Interleukin-6 and Disease". Journal of Chronic Fatigue Syndrome 4, n.º 1 (enero de 1998): 53–69. http://dx.doi.org/10.1300/j092v04n01_07.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

SEHGAL, PRAVIN B., LING WANG, RAVI RAYANADE, HENG PAN y LOLA MARGULIES. "Interleukin-6-Type Cytokinesa". Annals of the New York Academy of Sciences 762, n.º 1 (17 de diciembre de 2006): 1–14. http://dx.doi.org/10.1111/j.1749-6632.1995.tb32309.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Mehra, Reena. "Soluble Interleukin 6 Receptor". Archives of Internal Medicine 166, n.º 16 (18 de septiembre de 2006): 1725. http://dx.doi.org/10.1001/archinte.166.16.1725.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Henkin, Robert I., Loren Schmidt y Irina Velicu. "Interleukin 6 in Hyposmia". JAMA Otolaryngology–Head & Neck Surgery 139, n.º 7 (1 de julio de 2013): 728. http://dx.doi.org/10.1001/jamaoto.2013.3392.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Tesch, H., M. Jüjcler, S. Klein, H. Abts, A. Güjnther, G. R. F. Krueger y V. Diehl. "Hodgkin and Reed-Sternberg Cells Express Interleukin 6 and Interleukin 6 Receptors". Leukemia & Lymphoma 7, n.º 4 (enero de 1992): 297–303. http://dx.doi.org/10.3109/10428199209049781.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

Peters, Malte, Guido Blinn, Thomas Jostock, Peter Schirmacher, Karl–Hermann Meyer Zum Büschenfelde, Peter R. Galle y Stefan Rose–John. "Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration". Gastroenterology 119, n.º 6 (diciembre de 2000): 1663–71. http://dx.doi.org/10.1053/gast.2000.20236.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías sobre el tema "Interleukin-6" para otros tipos de fuentes:
Tesis Libros
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía